Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program is a research paper published in Annals of Epidemiology (2022). On theSindex it has a DataRank of 0.524. It has been cited 32 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01 CA251758
National Institutes of Health
Grant: CA047988
National Institutes of Health
Grant: CA182913
National Institutes of Health
Grant: HL080467
National Institutes of Health
Grant: HL043851
National Institutes of Health
Grant: HL099355
National Institutes of Health
Grant: EY06633
National Institutes of Health
Grant: EY18820
U.S. Department of Health and Human Services
Grant: 75N92021D00005
U.S. Department of Health and Human Services
Grant: 75N92021D00002
U.S. Department of Health and Human Services
Grant: 75N92021D00003
U.S. Department of Health and Human Services
Grant: P30 CA006973
U.S. Department of Health and Human Services
Grant: 75N92021D00004
U.S. Department of Health and Human Services
Grant: 75N92021D00001
U.S. Department of Health and Human Services
Grant: U01 CA86308
U.S. Department of Health and Human Services
Grant: CA40360
U.S. Department of Health and Human Services
Grant: U01CA202979
U.S. Department of Health and Human Services
Grant: CA097193
U.S. Department of Health and Human Services
Grant: HL26490
U.S. Department of Health and Human Services
Grant: HL34595
U.S. Department of Health and Human Services
Grant: CA34944
National Institute on Aging
Grant: U01 AG18033
Centers for Disease Control and Prevention
Grant: P30 CA047904
Centers for Disease Control and Prevention
Grant: P50 CA090440
Cancer Research Foundation in Northern Sweden
Grant: AMP19\u2013962
NHLBI NIH HHS
Grant: R01 HL043851
NCI NIH HHS
Grant: U01 CA086308
NCI NIH HHS
Grant: UM1 CA182913
World Health Organization
Grant: 001
NCI NIH HHS
Grant: U01 CA182913
NCI NIH HHS
Grant: R01 CA034944
NCI NIH HHS
Grant: R01 CA047988
NHLBI NIH HHS
Grant: R01 HL034595
NCI NIH HHS
Grant: U19 CA203654
Cancer Research UK
Grant: 29017
NHLBI NIH HHS
Grant: RC1 HL099355
NIA NIH HHS
Grant: U01 AG018033
NCI NIH HHS
Grant: R01 CA040360
NHLBI NIH HHS
Grant: R01 HL026490
NHLBI NIH HHS
Grant: R01 HL080467
NCI NIH HHS
Grant: R01 CA097193
NEI NIH HHS
Grant: R01 EY018820
NCI NIH HHS
Grant: R03 CA245979
National Institutes of Health
Grant: 5U01CA086308-05
CLUE STUDIES--EVALUATING BIOMARKERS OF CARCINOGENESIS
National Institutes of Health
Grant: 1U01CA202979-01
Southern Community Cohort Study
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01CA251758-04
Addressing racial disparities in lung cancer screening
National Institutes of Health
Grant: 5R01CA047988-10
TRIAL OF ASPIRIN AND VITAMIN E IN WOMEN
National Institutes of Health
Grant: 5U19CA203654-04
Integrative analysis of lung cancer etiology and risk
National Institutes of Health
Grant: 5R01EY018820-04
Folic Acid, B-Vitamins and AMD: Blood and Diet-based Studies
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 1R03CA245979-01A1
Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world
National Institutes of Health
Grant: 5R01CA040360-15
PHYSICIANS HEALTH STUDY--CONTINUED FOLLOW UP
National Institutes of Health
Grant: 5R01HL034595-02
A RANDOMIZED TRIAL OF ASPIRIN AND MORTALITY IN US MDS
National Institutes of Health
Grant: 2U01CA182913-06
Women's Health Study: Infrastructure support for cohort follow-up
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 1RC1HL099355-01
The Women's Health Study: Addition of New Data to Maximize its Research Impact
National Institutes of Health
Grant: 5R01CA097193-02
Physicians Health Study II: Prevention Trial of Vitamins
National Institutes of Health
Grant: 1R01HL080467-01
Womens Health Study: Continued Follow-Up
National Institutes of Health
Grant: 3P50CA090440-08S1
SPORE in Lung Cancer
National Institutes of Health
Grant: 5U01AG018033-03
GENE-ENVIRONMENT INTERACTIONS: THE ODYSSEY COHORT
Centre International de Recherche sur le Cancer
American Institute for Cancer Research
Canadian Institutes of Health Research
State of Maryland
Canada Research Chairs
Bristol-Myers Squibb
Lung Cancer Research Foundation
National Heart, Lung, and Blood Institute
World Health Organization
FWCI
3.53
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals